Point72 Asia (Singapore) Pte. Ltd. Neuronetics, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $381 Billion
- Q1 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Neuronetics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 14,980 shares of STIM stock, worth $60,219. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,980Holding current value
$60,219% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding STIM
# of Institutions
109Shares Held
19.5MCall Options Held
96.2KPut Options Held
58.4K-
Vanguard Group Inc Valley Forge, PA2.31MShares$9.27 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$6.99 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.42MShares$5.7 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$4.42 Million0.57% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$4.02 Million0.19% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $109M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...